Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients.
Risks of immune system treatments.
Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity.
The influence of disease duration, clinical course, and immunosuppressive therapy on the synthesis of intrathecal oligoclonal IgG bands in multiple sclerosis.
Newly onset sinus bradycardia in the context of multiple sclerosis relapse.
Identical lesion morphology in primary progressive and relapsing-remitting MS -an ultrahigh field MRI study.
Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study.
Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis.
Oligodendroglial membrane dynamics in relation to myelin biogenesis.
The Role of Endogenous IFN-β in the Regulation of Th17 Responses in Patients with Relapsing-Remitting Multiple Sclerosis.
Individual oligodendrocytes have only a few hours in which to generate new myelin sheaths in vivo.
Differential Reconstitution of T Cell Subsets following Immunodepleting Treatment with Alemtuzumab (Anti-CD52 Monoclonal Antibody) in Patients with Relapsing-Remitting Multiple Sclerosis.
Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation.
Transdermal Application of Myelin Peptides in Multiple Sclerosis Treatment.
Contribution of the oligodendrocyte lineage to CNS repair and neurodegenerative pathologies.
Statement on a nonproprietary name adopted by the USAN Council
Pharmacokinetics and pharmacodynamics of the interferon-betas, glatiramer acetate, and mitoxantrone in multiple sclerosis.
Rapid exacerbation of neuromyelitis optica after rituximab treatment.
Testicular hypofunction and multiple sclerosis risk: a record-linkage study.
Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year results.
Extensive bilateral lower extremity deep venous thrombosis in a patient on dimethyl fumarate.
Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosis.
LKB1/STRAD promotes axon initiation during neuronal polarization.
Subclinical myocardial dysfunction in multiple sclerosis patients remotely treated with mitoxantrone: evidence of persistent diastolic dysfunction.
Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol.
Pages
« first
‹ previous
…
53
54
55
56
57
58
59
60
61
…
next ›
last »